HIGHFLYER BLOODSTOCK AGENCY LIMITED

Company Registration Number:
04236470 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2021

Period of accounts

Start date: 01 January 2021

End date: 31 December 2021

HIGHFLYER BLOODSTOCK AGENCY LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2021

Balance sheet
Notes

HIGHFLYER BLOODSTOCK AGENCY LIMITED

Balance sheet

As at 31 December 2021


Notes

2021

2020


£

£
Fixed assets
Tangible assets: 3 4,190 4,490
Total fixed assets: 4,190 4,490
Current assets
Stocks: 215,250 17,000
Debtors:   156,227 144,329
Cash at bank and in hand: 860,865 850,698
Total current assets: 1,232,342 1,012,027
Creditors: amounts falling due within one year: 4 (298,592) (268,080)
Net current assets (liabilities): 933,750 743,947
Total assets less current liabilities: 937,940 748,437
Total net assets (liabilities): 937,940 748,437
Capital and reserves
Called up share capital: 2 2
Profit and loss account: 937,938 748,435
Shareholders funds: 937,940 748,437

The notes form part of these financial statements

HIGHFLYER BLOODSTOCK AGENCY LIMITED

Balance sheet statements

For the year ending 31 December 2021 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 22 July 2022
and signed on behalf of the board by:

Name: A R Bromley
Status: Director

The notes form part of these financial statements

HIGHFLYER BLOODSTOCK AGENCY LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2021

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

HIGHFLYER BLOODSTOCK AGENCY LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2021

2. Employees

2021 2020
Average number of employees during the period 4 4

HIGHFLYER BLOODSTOCK AGENCY LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2021

3. Tangible Assets

Total
Cost £
At 01 January 2021 9,010
At 31 December 2021 9,010
Depreciation
At 01 January 2021 4,520
Charge for year 300
At 31 December 2021 4,820
Net book value
At 31 December 2021 4,190
At 31 December 2020 4,490

HIGHFLYER BLOODSTOCK AGENCY LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2021

4. Creditors: amounts falling due within one year note

Trade Creditors 104842Corporation Tax 57588VAT 18552Directors Loans 117610